← Open Payments lookup

ARMINE GUKASYAN: Open Payments

NPI 1881280295 · BURBANK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$857 in 29 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $131 · 2025 $857

Food & beverage: $857
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.9$357
GENZYME CORPORATION5$160
ARS Pharmaceuticals Operations, Inc.3$74
Novartis Pharmaceuticals Corporation3$53
CSL Behring2$51
Optinose US, Inc.2$38
GlaxoSmithKline, LLC.1$31
Ionis Pharmaceuticals, Inc.1$30
AstraZeneca Pharmaceuticals LP1$25
Grifols USA, LLC1$24

Products named: DUPIXENT, NEFFY, Xhance, Rhapsido, Haegarda, NUCALA, DAWNZERA, BREZTRI.

Industry payments across CA — which companies pay providers there.